Business
Bausch + Lomb Announces Voluntary Recall of enVista Aspire™, enVista Envy™ and Certain enVista® Monofocal Intraocular Lenses
VAUGHAN, Ontario, March 27, 2025--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced a voluntary recall of intraocular lenses (IOLs) on its enVista platform. This action was taken out of an abundance of caution after the company received reports of complications, the cause of which could not immediately be explained.
About this update from Bausch + Lomb Corporation
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":4152,"height":327,"url":"https://media.zenfs.com/en/business-wire.com/a057bea13fec20b105c58339b490d337"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/NxOKCVjr6L8dZcVx3.UpPw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTc2O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/a057bea13fec20b105c58339b490d337","width":960,"height":76},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/DCinOqmr3pkY6NSahv_yxQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xOTA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/a057bea13fec20b105c58339b490d337","width":1200,"height":95}},"lazy":false},{"type":"text","content":"VAUGHAN, Ontario, March 27, 2025--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced a voluntary recall of intraocular lenses (IOLs) on its enVista platform. This action was taken out of an abundance of caution after the company received reports of complications, the cause of which could not immediately be explained.","length":435,"tagName":"p"},{"type":"text","content":""As much as we believe in the enVista platform, patient safety will always be our number one priority," said Brent Saunders, chairman and CEO, Bausch + Lomb. "Surgeons and patients trust Bausch + Lomb, and I believe that this voluntary recall is the best thing we can do to honor that trust."","length":312,"tagName":"p"},{"type":"text","content":"The recall is in response to an increased number of reports of toxic anterior segment syndrome (TASS) in conjunction with implantation of enVista Aspire, enVista Envy and certain enVista monofocal IOLs.","length":202,"tagName":"p"},{"type":"text","content":"TASS, a potential complication in any cataract surgery, is an inflammatory reaction inside the eye that can have a variety of causes. When it occurs, this complication typically appears 12 – 48 hours after eye surgery. All enVista TASS cases reported to Bausch + Lomb responded quickly to treatment, and none have required removal of the lens.","length":343,"tagName":"p"},{"type":"text","content":""These reports represent an extremely small percentage of implanted lenses, with a positive prognosis for e...